Growth-hormone secretagogues

If you’re here, you’re probably after some mix of better sleep, faster recovery, and a slow, stubborn recomposition, and you’ve read that growth-hormone peptides might get you there without injecting straight HGH.

Growth-hormone secretagogues are peptides that prod your own pituitary into releasing more of its own growth hormone, instead of adding HGH from outside. People run them for deeper sleep, quicker recovery, and slow body recomposition. The pharmacology is real (they measurably raise growth hormone), but most of the payoff people chase is still unproven in healthy adults.

This hub covers the whole class in plain English: how the two families actually work, which member has real FDA-backed evidence and which are research peptides, and where the community’s experience matches the science and where it runs ahead of it. Every compound named here has its own page below with the sourced detail.

What people actually use GH peptides for

People reach for GH secretagogues to chase three things: deeper sleep, faster recovery between hard training, and a slow lean-out where a little fat comes off and a little muscle hangs on. The typical buyer is already training hard, sleeping on purpose, and eating with intent, hunting the next small lever rather than a beginner looking for a shortcut.

Here’s the honest community read, and it’s more useful than any sales page. The most consistent thing people report, and the least hyped, is sleep: falling asleep faster and sleeping deeper, often inside the first week or two, most reliably on the ghrelin-mimetic side (ipamorelin and the oral MK-677). That one even has physiology behind it, since your biggest natural growth-hormone pulse rides on deep sleep anyway.

Recovery and body-composition reports are real too, just slower and mushier, and badly confounded, because the people running these are usually also lifting and dieting hard. It’s tough to separate what the peptide did from what the discipline did. And “recomposition” is where expectations outrun reality: anyone waiting on an HGH-style transformation from a pulse-nudging peptide tends to come away flat, and a good chunk of the early “gains” is water weight, not muscle. All of that is anecdotal, a community pattern rather than trial data, but it’s the pattern worth knowing before you read a single vendor page.

How growth-hormone secretagogues actually work

Growth-hormone secretagogues don’t add growth hormone to your system. They lean on the system you already have. Your pituitary fires out growth hormone in bursts, mostly during deep sleep, and these peptides press on the controls that set how big those bursts get. They split into two families, and that split is the whole key to the category.

The GHRH analogs are copies of growth-hormone-releasing hormone, your body’s own “release some GH” signal. This family includes sermorelin, CJC-1295, and the FDA-approved tesamorelin; sermorelin is literally the first 29 amino acids of your natural GHRH. Picture this family as pressing the accelerator.

The ghrelin mimetics (the GHRPs) copy ghrelin instead. This family includes ipamorelin and the oral MK-677, and they hit a different receptor that both fires a growth-hormone pulse and quiets somatostatin, the body’s “stop releasing GH” brake. Picture this family as lifting the brake.

Press the accelerator and lift the brake at the same time and you get a bigger surge than either move alone, which is exactly why the classic community stack pairs one from each family (a GHRH analog like CJC-1295 with a ghrelin mimetic like ipamorelin). That synergy isn’t bro-science; it’s well-documented pituitary physiology (secretagogue research on PubMed).

The contrast with injecting HGH is the entire appeal. Shooting synthetic HGH floods you with a flat, round-the-clock level and tells your own pituitary to clock off. Secretagogues work inside your existing feedback loops, so the rise looks more like your natural pulses and stays partly self-limiting. That’s the “more natural” pitch, and it’s a fair one, but more natural is not the same as proven safe. There’s also a catch the marketing skips: the long-acting versions (daily MK-677, or CJC-1295 built with the “DAC” tail) flatten the very pulse that was supposed to be the point.

One last thing that trips everyone up: the names are no help. The “-relin” ending is just the stem regulators hand out to GH-releasing peptides, so it flags the whole class without telling you the family. Ipamorelin (a ghrelin mimic) and sermorelin (a GHRH copy) share that ending and sit on opposite halves of the table. Read the family, not the last four letters.

What the evidence actually shows

One thing is settled across this whole class: dosing a secretagogue measurably raises growth hormone and IGF-1. The pituitary answers when you knock. What’s thin is whether the results people actually want (better recovery, more muscle, younger-looking skin, a longer healthspan) follow from that in healthy adults.

The outlier with real proof is tesamorelin, the one FDA-approved member (brand name Egrifta). Randomized trials got it cleared to shrink the deep visceral belly fat that builds up in HIV-associated lipodystrophy, and it does exactly that (FDA label via DailyMed). One honest caveat: that approval is for a specific medical problem, not gym recomposition or anti-aging, so every fitness use of it is off-label.

Sermorelin carries the longest medical history. It was an approved drug once (sold as Geref, used in growth-hormone-deficiency testing and pediatric treatment) with a reassuring safety record, but the branded product left the US market, and today’s “anti-aging” sermorelin is compounded and not backed by longevity trials.

MK-677 (ibutamoren) is the most-studied of the research-grade bunch. Taken as a daily oral, it reliably lifts growth hormone and IGF-1 for months and can add lean mass and appetite. But a large trial in older adults never turned that into clear functional benefit, and it carries real trade-offs: it raises blood sugar, can worsen insulin sensitivity, and holds water (indexed research on PubMed). Proven pharmacology, mixed payoff.

Ipamorelin and CJC-1295 are genuine growth-hormone releasers in the lab, but the recovery and body-composition outcomes people buy them for are mostly anecdotal, research peptides whose human outcome trials largely haven’t been run. So the honest synthesis for the class is this: the biology is real and well-mapped, and what’s still owed is outcome data in healthy people. The mechanism arrived first here, and the payoff studies are the part running late. That’s a reason to watch the space closely, not a reason to oversell it.

Who GH secretagogues are (and aren’t) for

Growth-hormone secretagogues fit someone already doing the hard parts (sleeping, training, and eating like they mean it) who wants a modest edge and likes the idea of nudging their own growth hormone rather than injecting HGH. If that’s you, set expectations at subtle, cumulative, and sleep-first, not a body swap.

They’re a poor fit as a shortcut. Nudging your pituitary does close to nothing if the sleep, food, and training underneath aren’t there, because the peptide raises your capacity to recover and build; it doesn’t create the work that gives you something to recover from. And anyone chasing an HGH-style before-and-after from the long-acting or oral versions is mostly signing up for the water retention (and, with oral MK-677, the blood-sugar creep) without the transformation.

One group has a hard, non-negotiable answer: tested athletes. Every compound in this class, GHRH analogs and ghrelin mimetics alike, sits on the WADA Prohibited List at all times under section S2 (WADA Prohibited List). If you’re drug-tested in any real federation, this entire category is off the table for competition, full stop. And if you’re managing an actual medical condition, none of these are a do-it-yourself substitute for endocrine care.

So, back to the sleep and the slow recomp you walked in wanting. The honest version is that the pituitary really does answer when these peptides knock: the biology is real, the mechanism is mapped, and the open question is how much of the downstream payoff shows up for a healthy adult chasing recovery rather than treating a disease. Start with a specific compound below to see where its evidence actually stands. If you go further, the practical specifics (the doses people report, how to reconstitute a vial, what can and can’t share a syringe) live on each compound’s page and in the reconstitution calculator and mixing compatibility reference. For the wider map, GH peptides get stacked with GLP-1 drugs for fat loss, overlap with healing and recovery peptides on the recovery goal, and file under the broader longevity bet, or you can browse the full peptide library.